News

A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.

Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.

New Cardinal Health Specialty Solutions research shares inside information about oncologists’ views about targeted therapies.

FDA’s approval of a cannabidiol (CBD) medicine to treat seizures associated with 2 severe forms of epilepsy is a positive sign for other CBD drugs under development.

The law opens up new options for terminally ill patients. But how will it impact managed care organizations?

FDA’s plan to evaluate gene therapies’ impact on surrogate end points is amping up concerns among payers. Here’s why

Cambia Health Solutions’ Laurent Rotival, MS, reveals what can happen when Amazon’s principles muscle in on the traditional healthcare model.

Trust in the healthcare sector is dropping, a warning sign to executives. Here’s four ways how to reclaim it.

Trepidation by providers to take on more risk is threatening the road to value-based care.

Benefit cuts and increasing prices are creating medical debt and bankruptcies. Some consumers respond by avoiding healthcare or abandoning coverage. Their alternative? They don’t pay providers.

Joslin Diabetes Center researchers reveal startling study results linking decades of having type 1 diabetes and mental abilities.

A new study has revealing findings about the link between stress at work and heart disease and diabetes.

A new Accenture study reveals how the aggressive adoption of artificial intelligence plays a greater role in healthcare decision making.

To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.  

A new annual report from PwC as reveals how employers struggle to contain employee coverage costs.

The manufacturer of bevacizumab (Avastin), snagged FDA approval for yet another type of cancer.

The right technology will enable increased population health efficiencies while simultaneously reducing the resource burden associated with managing that effort. Here are three specific capabilities to look for.

Five generations make up the nation’s current workforce and differences exist in each one. Here’s a multi-faceted approach employers can take to engage a multi-generational workforce in their healthcare benefits.

University of Pennsylvania researchers share evidence-based strategies for reducing unplanned emergency department and hospitalizations of patients with cancer.

Starting or strengthening a provider-led health plan leads to true integration, resulting in quality care.

Healthcare experts weigh in on the president’s plan to lower drug prices. Here’s what they said.

FDA approved the first biosimilar to Neulasta, as well as a new combination treatment for osteoarthritis pain and hypertension and a new drug to treat chronic lymphocytic leukemia.

The manufacturer of two cancer drugs hiked the price on the medicines despite President Donald Trump’s new plan to lower drug prices.

Virtually all healthcare leaders recognize the value of content creation, yet the use of a well-defined content strategy is rare. Here’s how to get yours.

A Quest Diagnostics study sheds light on Medicare patients with multiple chronic conditions and the top three care gaps.